Please login to the form below

Not currently logged in
Email:
Password:

infectious diseases

This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.

Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19

Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19

The ACTT-2 trial, which was sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID), evaluated a 4mg dose of Olumiant (baricitinib) given alongside remdesivir versus remdesivir alone

Latest news

More from news
Approximately 4 fully matching, plus 195 partially matching documents found.

Latest Intelligence

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    I don’t think the ongoing trials will tell us a lot,” said H Clifford Lane, clinical director at the National Institutes of Allergy and Infectious Diseases (NIAID). ... IL-6 is a type of cytokine that plays an important role in immune response and is

  • We’ll need more than a spoonful of sugar to counter vaccine hesitancy We’ll need more than a spoonful of sugar to counter vaccine hesitancy

    It is, therefore, critical that action is taken to stop the re-emergence of dangerous infectious diseases.

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    He moved to the University of Rochester as Associate Professor for 5 years, before becoming Infectious Diseases Division Chief and tenured full Professor at the University of California, Davis. ... In 2005, he joined the Novartis Institutes for

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    A study recently reported in The Lancet Infectious Diseases found that antibiotics are now failing to work in a fifth of patients who suffer an infection after hospital surgery.

  • Deal Watch February 2016 Deal Watch February 2016

    Alere has annual sales of approximately $2.5bn from a portfolio of point-of-care products in areas including cardiometabolic, infectious diseases such as HIV, malaria, syphilis, E. ... Pronutria's focus is on the development of therapeutics and

More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 38 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics